MY008211A tablets ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
62発作性夜間ヘモグロビン尿症1

62. 発作性夜間ヘモグロビン尿症


臨床試験数 : 292 薬物数 : 151 - (DrugBank : 49) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 108
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05642585
(ClinicalTrials.gov)
May 27, 202230/11/2022A Study of Single-dose MY008211A in Healthy AdultsA Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Doses Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic/Pharmacodynamics Characteristics of MY008211A Tablets in Healthy Adult VolunteersParoxysmal Nocturnal HemoglobinuriaDrug: MY008211A tablets;Drug: PlaceboWuhan Createrna Science and Technology Co., LtdNULLActive, not recruiting18 Years45 YearsAll46Phase 1China